GlassScriptPhysician profile
Akash Patel
NPI 1902433204
$3,323.01
in general payments reported to CMS, 2019-2025
8 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,168 · 2023: $537 · 2024: $594 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,906 · Education: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,906.11 |
| Education | $249.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,167.82 | 2022 | |
| Abiomed | $693.72 | 2024-2025 | Impella |
| Boston Scientific Corporation | $521.74 | 2024-2025 | Accolade Sr, Avvigo Guidance System, Resonate El Icd Vr |
| Abbvie INC. | $385.56 | 2023-2024 | |
| Abbott Laboratories | $351.17 | 2023 | Ensite, Assurity |
| Novartis Pharmaceuticals Corporation | $114.41 | 2025 | |
| Janssen Pharmaceuticals, INC | $65.47 | 2024 | Xarelto |
| Edwards Lifesciences Corporation | $23.12 | 2023 | Pascal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akash Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.